Data from the Phase III MINT trial found that Uplizna demonstrated a greater reduction in Myasthenia Gravis Activities of ...

It's a project the company said shows "glimmers of AI systems that tackle challenges with increasing competence, not just ...

Generalized anxiety disorder (GAD) is a type of excessive worrying that consumes the lives of people who experience it. Symptoms can include fatigue, headaches, shortness of breath, and having a hard ...

The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...

Two out of three family members charged in the death of a 12-year-old West Haven boy pleaded guilty on Thursday, in return ...

Nvidia (NVDA) announced a portfolio of technologies to supercharge humanoid robot development, including Nvidia Isaac GR00T N1, the world’s ...

Zai Lab Limited's stock surged 105% in a year. Click to explore ZLAB's $2bn revenue goal, key drugs, and strategic ...

The FDA has approved an expanded indication of Soliris, an IV-administered monoclonal antibody for patients aged 6 years and ...

A new study from the Research Center for Child Psychiatry at the University of Turku in Finland screened school-age children ...

Researchers have utilized machine learning to identify key predictors of recovery in individuals with generalized anxiety ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...

AI could revolutionize anxiety treatment! By analyzing data, it helps clinicians personalize care for generalized anxiety ...